Polymeric Micelles Based on Hyaluronic Acid and Phospholipids: Design, Characterization, and Cytotoxicity

被引:17
作者
Saadat, Ebrahim [1 ]
Amini, Mohsen [2 ]
Dinarvand, Rassoul [1 ]
Dorkoosh, Farid A. [1 ]
机构
[1] Univ Tehran Med Sci, Dept Pharmaceut, Fac Pharm, Tehran 1439956131, Iran
[2] Univ Tehran Med Sci, Dept Med Chem, Fac Pharm, Tehran 141556451, Iran
关键词
biocompatibility; copolymers; micelles; self-assembly; DRUG-DELIVERY; IN-VITRO; HYPERBRANCHED POLYMERS; ANTITUMOR-ACTIVITY; NANOCARRIERS; CHOLESTEROL; CARRIERS; PHOSPHATIDYLETHANOLAMINE; PHARMACOKINETICS; NANOPARTICLES;
D O I
10.1002/app.40944
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Novel amphiphilic copolymers were synthesized and characterized by H-1 NMR using Hyaluronic acid (HA) as a hydrophilic part and phosphatidylethanolamine (PE) including 1,2-dimiristoyl-sn-glycerol-3-phosphatidylethanolamine (DMPE) and 1,2-distearoyl- sn-glycerol-3-phosphatidylethanolamine (DSPE) as a hydrophobic segment. The newly developed HA-PE copolymers form a micelle in an aqueous media. The micellar properties, including critical micelle concentration (CMC) with pyrene as a fluorescence probe and micelle morphology, using transmission electron microscopy were assessed. It was found that the CMC values for HADMPE and HA-DSPE were 15.5 and 13.4 lg/mL, respectively. Also micelles were spherical in shape and within the size range of 162214 nm. The solubility of cholesterol, a highly hydrophobic compound, was enhanced to 0.25 mg/mL which is much higher than it is in water (0.0001 mg/mL). In vitro cytotoxicity assay of HA-PE copolymers showed no toxicity on human breast cancer cell line (MCF-7). These results suggest that HA-PE micelles could be considered as a promising carrier for delivery of hydrophobic compounds. (C) 2014 Wiley Periodicals, Inc.
引用
收藏
页数:8
相关论文
共 41 条
[11]   Polymeric micelles drug delivery system in oncology [J].
Gong, Jian ;
Chen, Meiwan ;
Zheng, Ying ;
Wang, Shengpeng ;
Wang, Yitao .
JOURNAL OF CONTROLLED RELEASE, 2012, 159 (03) :312-323
[12]   Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel [J].
Immordino, ML ;
Brusa, P ;
Arpicco, S ;
Stella, B ;
Dosio, F ;
Cattel, L .
JOURNAL OF CONTROLLED RELEASE, 2003, 91 (03) :417-429
[13]   Facile Fabrication of Thermo-Responsive and Reduction-Sensitive Polymeric Micelles for Anticancer Drug Delivery [J].
Jiang, Xulin ;
Li, Lihua ;
Liu, Jia ;
Hennink, Wim E. ;
Zhuo, Renxi .
MACROMOLECULAR BIOSCIENCE, 2012, 12 (05) :703-711
[14]   Amphiphilic comb-like polymers based on poly(oxyethylene)s as drug-delivery carriers [J].
Kim, Ki-Hyun ;
Lee, Jong-Chan ;
Lee, Jonghwi .
MACROMOLECULAR BIOSCIENCE, 2008, 8 (04) :339-346
[15]   Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery [J].
Lavasanifar, A ;
Samuel, J ;
Kwon, GS .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (02) :169-190
[16]   Hyaluronic acid-paclitaxel conjugate micelles: Synthesis, characterization, and antitumor activity [J].
Lee, Hyukjin ;
Lee, Kyuri ;
Park, Tae Gwan .
BIOCONJUGATE CHEMISTRY, 2008, 19 (06) :1319-1325
[17]   In vivo NIRF Imaging of Tumor Targetability of Nanosized Liposomes in Tumor-Bearing Mice [J].
Lee, Sangmin ;
Lee, Seung-Young ;
Park, Sangjin ;
Ryu, Ju Hee ;
Na, Jin Hee ;
Koo, Heebeom ;
Lee, Kyung Eun ;
Jeon, Hyesung ;
Kwon, Ick Chan ;
Kim, Kwangmeyung ;
Jeong, Seo Young .
MACROMOLECULAR BIOSCIENCE, 2012, 12 (06) :849-856
[18]   Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery [J].
Liu, Yanhua ;
Sun, Jin ;
Cao, Wen ;
Yang, Jianhong ;
Lian, He ;
Li, Xin ;
Sun, Yinghua ;
Wang, Yongjun ;
Wang, Siling ;
He, Zhonggui .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 421 (01) :160-169
[19]   Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery [J].
Luo, Y ;
Kirker, KR ;
Prestwich, GD .
JOURNAL OF CONTROLLED RELEASE, 2000, 69 (01) :169-184
[20]   Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect [J].
Maeda, H. ;
Bharate, G. Y. ;
Daruwalla, J. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 71 (03) :409-419